Endotoxin and ischemic preconditioning: TNF-α concentration and myocardial infarct development in rabbits

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 277, Issue 6 46-6, 1999, Pages

  Belosjorow, Sergej ^a   Schulz, Rainer ^a   Börge, Hilmar ^a   Schade, F Ulrich ^b   Heusch, Gerd ^a,c  

^a Pathophysiologie Klin F   (Germany)

^b Zentrum für Minimal Invasive Chirurgie   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Ischemic preconditioning; Tumor necrosis factor

Indexed keywords

ENDOTOXIN; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DISEASE ASSOCIATION; ENZYME ACTIVITY; HEART FAILURE; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; MACROPHAGE FUNCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; RISK ASSESSMENT;

EID: 0033373440     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1999.277.6.h2470     Document Type: Article

References (34)

1. Brown, J. M., M. A. Grosso, L. S. Terada, G. Whitman, A. Banerjee, C. W. White, A. H. Harken, and J. E. Repine. Endotoxin pretreatment increases endogenous myocardial catalase activity and decreases ischemia-reperfusion injury of isolated rat hearts. Proc. Natl. Acad. Sci. USA 86: 2516-2520, 1989.
2. Bryant, D., L. Becker, J. Richardson, J. Shelton, F. Franco, R. Peshock, M. Thompson, and B. Giroir. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-α. Circulation 97: 1375-1381, 1998.
3. Ceconi, C., S. Curello, T. Bachetti, A. Corti, and R. Ferrari. Tumor necrosis factor in congestive heart failure: a mechanism of disease for the new millenium? Prog. Cardiovasc. Dis. 41: 25-30 1998.
4. Ehring, T., M. Krajcar, D. Baumgart, S. Kompa, M. Hümmelgen, and G. Heusch. Cholinergic and a-adrenergic coronary vasomotion with increasing ischemia-reperfusion injury. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H886-H894, 1995.
5. Eising, G. P., L. Mao, G. W. Schmid-Schönbein, R. L. Engler, and J. Ross. Effects of induced tolerance to bacterial lipopolysaccharide on myocardial infarct size in rats. Cardiovasc. Res. 31: 73-81, 1996.
6. Espevik, T., and J. Nissen-Meyer. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods 95: 99-105, 1986.
7. Flach, R., and F. U. Schade. Peritoneal macrophages from endotoxin-tolerant mice produce an ibhibitor of tumor necrosis factor a synthesis and protect against endotoxin shock. J. Endotoxin Res. 4: 241-250, 1997.
8. Frangogiannis, N. G., M. L. Lindsey, L. H. Michael, K. A. Yoouker, R. B. Bressler, L. H. Mendoza, R. N. Spengler, C. W. Smith, and M. L. Entman. Resident cardiac mast cells degranulate and release preformed TNF-α, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion. Circulation 98: 699-710, 1998.
9. Giroir, B. P., H. J. Johnson, T. Brown, G. L. Allen, and B. Beutler. The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. J. Clin. Invest. 90: 693-698, 1992.
10. Greisman, S. E., J. F. A. Carozza, and J. D. Hills. Mechanism of endotoxin tolerance. Relationship between tolerance and reticuloendothelial system phagocytic activity in the rabbit. J Exp. Med. 117: 663-674, 1963.
11. Grunfeld, C., and M. A. Palladino. Tumor necrosis factor: immunologic, antitumor, metabolic, and cardiovascular activities. Adv. Intern. Med. 35: 45-72, 1990.
12. Gurevitch, J., I. Frolkis, Y. Yuhas, B. Lifschitz-Mercer, E. Berger, Y. Paz, M. Matsa, A. Kramer, and R. Mohr. Anti-tumor necrosis factor-α improves myocardial recovery after ischemia and reperfusion. J. Am. Coll. Cardiol. 30: 1554-1561, 1997.
13. Gurevitch, J., I. Frolkis, Y. Yuhas, Y. Paz, M. Matsa, R. Mohr, and V. Yakirevich. Tumor necrosis factor-α is released from the isolated heart undergoing ischemia and reperfusion. J. Am. Coll. Cardiol. 28: 247-252, 1996.
14. Irwin, M. W., S. Mak, D. L. Mann, R. Qu, J. M. Penninger, A. Yan, F. Dawood, W.-H. Wen, Z. Shou, and P. Liu. Tissue expression and immunolocalization of tumor necrosis factor-α in postinfarction dysfunctional myocardium. Circulation 99: 1492-1498, 1999.
15. Kapadia, S., J. Lee, G. Torre-Amione, H. H. Birdsall, T. S. Ma, and D. L. Mann. Tumor necrosis factor-α gene and protein expression in adult feline myocardium after endotoxin administration. J. Clin. Invest. 96: 1042-1052, 1995.
16. Kowallik, P., R. Schulz, B. D. Guth, A. Schade, W. Paffhausen, R. Gross, and G. Heusch. Measurement of regional myocardial blood flow with multiple colored microspheres. Circulation 83: 974-982, 1991.
17. Liu, G. S., J. Thornton, D. M. van Winkle, A. W. H. Stanley, R. A. Olsson, and J. M. Downey. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 84: 350-356, 1991.
18. Majetschak, M., R. Flach, E. Kreuzfelder, V. Jennissen, T. Heukamp, F. Neudeck, K. P. Schmit-Neuerburg, U. Obertacke, and F. U. Schade. The extent of traumatic damage determines a graded depression of the endotoxin responsiveness of peripheral blood mononuclear cells from patients with blunt injuries. Crit. Care Med. 27: 313-318, 1999.
19. Meldrum, D. R. Tumor necrosis factor in the heart. Am. J. Physiol. 274 (Regulatory Integrative Comp. Physiol. 43): R577-R595, 1998.
20. Meldrum, D. R., C. A. Dinarello, B. D. Shames, J. C. Cleveland, Jr., B. S. Cain, A. Banerjee, X. Meng, and A. H. Harken. Ischemic preconditioning decreases postischemic myocardial tumor necrosis factor-α production. Potential ultimate effector mechanism of preconditioning. Circulation 98, Suppl: II-214-II-219, 1998.
21. Meng, X., L. Ao, J. M. Brown, D. R. Meldrum, B. C. Sheridan, B. S. Cain, A. Banerjee, and A. H. Harken. LPS induces late cardiac functional protection against ischemia independent of cardiac and circulating TNF-α. Am. J. Physiol. 273 (Heart Circ. Physiol. 42): H1894-H1904, 1997.
22. Meng, X., L. Ao, D. R. Meldrum, B. S. Cain, B. D. Shames, G. H. Selzmann, A. Banerjee, and A. H. Harken. TNF-α and myocardial depression in endotoxemic rats: temporal discordance of an obligatory relationship. Am. J. Physiol. 275 (Regulatory Integrative Comp. Physiol. 44): R502-R508, 1998.
23. Node, K., M. Hasegawa, and S. Suzuki. Lipopolysaccharide enhances production of adenosine via induction of ecto-5′-nucleotidase, and provides cardioprotection (Abstract). Circulation 94: 2460, 1996.
24. Oral, H., G. W. Dorn, and D. L. Mann. Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-α in the adult mammalian cardiac myocyte. J. Biol. Chem. 272: 4836-4842, 1997.
25. Rowland, R. T., J. C. Cleveland, Jr., X. Meng, L. Ao, A. H. Harken, and J. M. Brown. A single endotoxin challenge induces delayed myocardial protection against infarction. J. Surg. Res. 63: 193-198, 1996.
26. Schade, F. U., R. Flach, S. Flohe, M. Majetschak, E. Kreuzfelder, E. Dominguez-Fernandez, J. Börgermann, and U. Obertacke. Endotoxin tolerance. In: Endotoxin in Health and Disease, edited by H. Brade, D. C. Morrison, S. Opal, and S. Vogel. New York: Marcel Dekker, 1999, p. 751-767.
27. Schade, F. U., Schlegel, J., Hofmann, K., Brade, H., and Flach, R. Endotoxin-tolerant mice produce an inhibitor of tumor necrosis factor synthesis. J. Endotox. Res. 3: 455-462, 1996.
28. 2+-independent nitric oxide synthase in the myocardium. Br. J. Pharmacol. 105: 575-580, 1992.
29. Song, W., B. L. Furman, and J. R. Parratt. Delayed protection against ischaemia-induced ventricular arrhythmias and infarct size limitation by the prior administration of Escherichia coli endotoxin. Br. J. Pharmacol. 118: 2157-2163, 1996.
30. Suffredini, A. F., R. E. Fromm, M. M. Parker, M. Brenner, J. A. Kovacs, R. A. Wesley, and J. E. Parrillo. The cardiovascular response of normal humans to the administrations of endotoxin. N. Engl. J. Med. 32: 280-287, 1989.
31. Sugishita, K., K. Kinugawa, T. Shimizu, K. Harada, H. Matsui, T. Takahashi, T. Serizawa, and O. Kohmoto. Cellular basis for the acute inhibitory effects of IL-6 and TNF-α on excitation-contraction coupling. J. Mol. Cell. Cardiol. 31: 1457-1467, 1999.
32. Vaddi, K., F. A. Nicolini, P. Mehta, and J. L. Mehta. Increased secretion of tumor necrosis factor-α and interferon-γ by mononuclear leukocytes in patients with ischemic heart disease. Circulation 90: 694-699, 1994.
33. Vatner, S. F., T. A. Patrick, D. R. Knight, W. T. Manders, and J. T. Fallon. Effects of calcium channel blocker on responses of blood flow, function, arrhythmias, and extent of infarction following reperfusion in conscious baboons. Circ. Res. 62: 105-115, 1988.
34. Ytrehus, K., Y. Liu, A. Tsuchida, T. Miura, G. S. Liu, X.-M. Yang, D. Herbert, M. V. Cohen, and J. M. Downey. Rat and rabbit heart infarction: effects of anesthesia, perfusate, risk zone, and method of infarct sizing. Am. J. Physiol. 267 (Heart Circ. Physiol. 36): H2383-H2390, 1994.